3 unknown, 1 active not recruiting, 1 completed, 1 not yet recruiting. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 3, Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
Follow Decompensated Liver Cirrhosis: new trials by email Literature Review of Decompensated Liver Cirrhosis trials Research Report on Decompensated Liver Cirrhosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis Atorvastatin 20 mg, Placebo - Decompensated Liver Cirrhosis, Cirrhosis | Phase 2 | Recruiting | CAMC Health System | 50 | 2025-09-09 | 2026-02-25 |
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver | Phase 1 / Phase 2 | Active not recruiting | Resolution Therapeutics Limited | 30 | 2024-10-15 | 2026-10-05 |
| Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis Human Umbilical Cord Mesenchymal Stem Cells - Decompensated Liver Cirrhosis | Phase 1 / Phase 2 | Not yet recruiting | Asia Cell Therapeutics (Shanghai) Co., Ltd. | 18 | 2023-07-30 | 2023-07-17 |
| Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis MSC-derived exosomes - Decompensated Liver Cirrhosis | Phase 2 | Unknown | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | 15 | 2023-05-26 | 2023-05-23 |
| Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis umbilical cord-derived mesenchymal stem cell, Comprehensive treatment - Decompensated Liver Cirrhosis | Phase 2 | Unknown | Beijing 302 Hospital | 200 | 2019-05-20 | 2019-05-10 |
| Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis UC-MSC - Decompensated Liver Cirrhosis | Phase 2 | Unknown | Shandong Qilu Stem Cells Engineering Co., Ltd. | 252 | 2018-06-01 | 2018-05-18 |
| A Study of ADR-001 in Patients With Liver Cirrhosis Mesenchymal stem cell - Decompensated Liver Cirrhosis | Phase 1 / Phase 2 | Completed | Rohto Pharmaceutical Co., Ltd. | 21 | 2017-07-20 | 2023-07-06 |
Fibrosis (2) · Liver Cirrhosis (2) · Ascites (1) · End Stage Liver Disease (1) · Hepatic Encephalopathy (1) · Jaundice (1) · Liver Diseases (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Digestive System Diseases (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Central Nervous System Diseases (1) · Fibrosis (1) · Hepatic Insufficiency (1) · Hyperbilirubinemia (1) · Liver Diseases (1) · Liver Failure (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1) · Signs and Symptoms (1)
Atorvastatin (1)
Asia Cell Therapeutics (Shanghai) Co., Ltd. (1) · Beijing 302 Hospital (1) · CAMC Health System (1) · Research Institute for Gastroenterology and Liver Diseases (RIGLD) (1) · Resolution Therapeutics Limited (1) · Rohto Pharmaceutical Co., Ltd. (1) · Shandong Qilu Stem Cells Engineering Co., Ltd. (1)
China (1) · Iran (1) · Japan (1) · Spain (1) · United Kingdom (1) · United States (1)
Behzad Hatami, MD (1) · Fu-Sheng Wang (1) · Jingbo Wang (1) · Lungen Lu, MD (1) · Nadeem Anwar, MD (1) · Shuji Terai, MD (1)